BVF »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by BVF

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by BVF from 13F filings

Historical chart of BVF investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by BVF

Quarter filed Position value Share count Share price at filing
2023-12-31 $31M 2.7M 11.23
2023-09-30 $32M 2.7M 11.68

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Axsome Therapeutics (AXSM)
Protagonist Therapeutics (PTGX)
Kymera Therapeutics (KYMR)
Mirum Pharmaceuticals (MIRM)
Olema Pharmaceuticals (OLMA)
Ionis Pharmaceuticals (IONS)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Galapagos Nv Spon Adr (GLPG)
Merus N V (MRUS)
Repare Therapeutics Ord (RPTX)
Ac Immune Sa SHS (ACIU)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for BVF

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

QVT Financial
Viking Global Investors
Wellington Management Company
Baker Bros. Advisors
Vanguard Group
Anchorage Capital Group
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Norges Bank Investment Management
BVF
Bank of New York Mellon
Octagon Capital Advisors
Tejara Capital
Charles Schwab Investment Management

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017